• Updates Archive

    05.31.13 - Genomic Findings, Clinical Trials & Patient Activities

    The past few months have seen a flurry of significant research findings. A major scholarly article depicts the landscape of ACC genomics and four reports from ACC clinical trials point to encouraging results. Meanwhile, patients gathered, supported each other and raised funds for more research.

    More »

    12.20.12 - ACCRF Year End Letter

    Highlights from a remarkable year include a third Dovitinib clinical trial, $8 million in NIH grants and a revamped website.

    More »

    09.20.12 - 3rd Workshop on Salivary Gland Tumors

    The re-invigoration of the field of salivary gland tumor research over the past 6 years has been a very welcome development for ACC patients. A recent NIH workshop attracted many new investigators and highlighted many active collaborations.

    More »

    02.03.12 - Dovitinib Study Opens at the University of Virginia

    The University of Virginia has begun screening ACC patients with progressive disease for a new clinical trial. Supported by Novartis Pharmaceuticals, the Phase II study will enroll 10 patients to determine the efficacy and safety of the oral drug Dovitinib, an inhibitor of FGFR, VEGFR and PDGFR.

    More »

    01.09.12 - RFAs for Salivary Gland Tumor Research

    The National Institute of Dental and Craniofacial Research (NIDCR) posted two Requests for Applications (RFAs) seeking grant proposals to enhance basic and translational research on salivary gland tumors (SGTs). This anticipated commitment of approximately $8 million over the next four years underscores the continuing strong leadership of NIDCR in this under-studied field.

    More »

    12.21.11 - ACCRF Year End Letter (2011)

    Your support made 2011 a banner year! And together we can do even more in 2012! Your generosity and the deep commitment of our affiliated researchers have allowed us to reach some crucial milestones and chart the path forward for more successes.

    More »

    07.26.11 - Update on Progressive ACC

    ACC Patients with tumors that are clearly growing face a journey with few signposts. This update provides information on treatment options including radiation, tumor profiling and clinical trials.

    More »

    11.18.10 - Guide to Systemic Therapy

    ACC patients dealing with progressive disease face many uncertainties. This guide for patients and physicians provides context and information for decisions about clinical trials.

    More »

    11.17.10 - ACC Patient Community Survey

    ACCRF and ACCOI conducted a joint survey of the ACC patient community to gauge the priorities, communication preferences and volunteering interests of survivors, families, friends and physicians. The response was dramatic and the organizations are coordinating to meet the needs of the community.

    More »

    08.21.10 - ACCRF Accomplishments

    The pace of research progress in ACC has quickened over the past two years, providing the patient community with justifiable hope for improved outcomes in the coming years. Here we review some of the most significant advances as well as key goals for the remainder of this year.

    More »